Where can you get compounded semaglutide online?

Use the ingredient and formulation together

A search for compounded semaglutide can produce injectable offers, sublingual drops and other preparations under the same ingredient heading. Those are distinct product descriptions. Gentle Health, for example, advertises both injections and drops under the tongue. The directory preserves those labels rather than converting everything into an interchangeable semaglutide price. Select the formulation you are researching before comparing the recurring bill. [1]

Compounded semaglutide is also a different category from branded Wegovy or Ozempic. FDA distinguishes compounded preparations from approved finished drugs and says they are not FDA-approved. A provider that prescribes an approved brand is not automatically a compounded-semaglutide source, and the word semaglutide alone does not identify the proposed product. Ask the service for the exact name and formulation it intends to arrange after evaluation. [5]

Start with the recorded roster, then confirm current access

The table below is generated from provider records, not from a separately maintained promotional list. Each row shows the offering recorded in our catalog and the source date attached to that claim. These dates matter: preparing this article in October does not make an older provider observation an October verification. Open the linked profile to inspect the organization’s clinical process, limitations, geographic evidence and price details together. [1][2][3][4]

The table answers which organizations advertise the product, not which prescription is available to a particular patient today. A company may change its pharmacy arrangements or offer only some preparations in a state. Use the medication’s state page to narrow the roster and then verify the actual service with the provider. We preserve a distinction between general service coverage and directly evidenced product-state availability; neither should be silently promoted into a pharmacy order guarantee. [7][8]

Understand the post-shortage limitation

FDA’s current compounding-policy notice states that semaglutide is not on the drug shortage list or the 503B bulks list. The shortage-era justification for routine copies should therefore not be treated as current permission for every advertised offer. FDA describes conditions governing patient-specific compounding and restrictions on preparations that are essentially copies. Those rules concern the actual compounder and prescription, not whether an enrollment site remains online. [6]

A lower price, convenient delivery or a subscription name does not establish the necessary prescription-specific basis. The clinician and dispensing pharmacy must address the circumstances under the current rules. Our legal-status guide explains the regulatory categories; this access guide does not determine whether an individual preparation or business arrangement satisfies them. A provider’s description of customization should be read as its claim, not a regulatory approval from this directory. [6]

Compare recorded charges without losing the terms

For documented recurring injection offers with standard-dose coverage, the directory’s calendar-month examples run from $135 to $348; four-week examples run from $199 to $289. Their source-check range is 2026-10-02–2026-10-05. These are catalog facts for the qualifying offers, not the full advertised roster or a guarantee of the checkout total. An unknown dose or fee remains a limitation. [1][2][3]

The detailed comparison page separates first payments, prepaid commitments and recurring charges. Use it when a plan displays a low monthly equivalent but collects a longer term in advance. Do not compare an injection recurring charge with a sublingual offer’s headline as if the route and financial commitment were identical. The question here is where a service is advertised; the comparison explains the price evidence that can actually be supported. [1][2]

Identify the prescriber and dispensing pharmacy

FDA’s online-pharmacy guidance recommends checking for a valid prescription and verifiable licensing. Ask which clinician evaluates the request and which pharmacy fills it in your state. A telehealth brand, clinical organization and pharmacy can be separate entities. Keep their names and responsibilities clear so you know where to take a clinical question and where to take a fulfillment question. A favorable review score is not a pharmacy license. [8]

Be cautious about products sold as research material or through a process that avoids a prescription. Those are not equivalent to a clinician-supervised telehealth program. This directory lists recorded care services; it does not authenticate a vial from an unrelated seller or review a patient’s treatment plan. The prescribing service and licensed pharmacy are the relevant contacts for product identification and the current transaction. [8][5]

Use the state page before beginning enrollment

The medication directory leads to the state pages where geographic evidence and provider lists can be considered together. State pages are our deepest geographic level; there are no city pages implying a different local supply. If your state page has not yet been published, consult the provider’s own coverage information and confirm the visit location directly. A held page is a publishing status, not evidence that care is prohibited in that state. [7]

A pharmacy name is useful evidence

If a company names its pharmacy partners, check which one will actually handle your request. Gentle Health currently names multiple pharmacy partners and says selection depends on medication and location. That company statement is more specific than a generic licensed-pharmacy slogan, but it still does not identify the pharmacy for an individual order. Confirm the legal pharmacy name with the care service, then use the relevant board’s official lookup. Do not interpret a partner list as approval of every preparation a pharmacy might offer. [1][8]